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A specific polyclonal antibody was used to investigate he subcellular distribution of the small GTPase, rabl 1 p, in the neuroendocrine cell line, 
PC12. We took advantage of a previously described pulse-chase protocol based on sulfation [1] to examine the distribution of rabl 1 along the 
secretory pathway. Using the rabl 1 antiserum, but not serum depleted of rabl 1 antibodies, we were able to specifically immunoisolate markers 
of the constitutive and the regulated secretory pathway in the trans-Golgi network (TGN) as well as after their exit from this compartment 
(constitutive s cretory vesicles, immature, and mature secretory granules). We therefore conclude that rabl lp is associated with the TGN and with 
TGN-derived vesicles of both the constitutive and the regulated secretory pathway in PC12 cells. 
Small GTP-binding protein; Secretion; Immunoisolation 
1. INTRODUCTION 
Small GTPases of the rab-thmily have been shown to 
play a critical role in vesicular traffic in eucaryotic cells 
[2]. Since their discovery the number of rab-proteins has 
increased such that the family now comprises more than 
30 members [3]. The differential distribution of the rab- 
proteins to distinct intracellular compartments sug- 
gested that different members of the family might con- 
vey specificity to different intracellular pathways possi- 
bly by providing the vesicles with a proof-reading mech- 
anism to ensure correct argeting [4]. However, the pre- 
cise function of rab proteins in this complex process is 
not yet understood. We have investigated the subcellu- 
lar distribution of rabllp [5], which although ubiqui- 
tously expressed, has been reported to be more abun- 
dant in tissues with a high level of secretion [6]. This 
observation suggested that rabl lp might play a role in 
the exocytic pathway. All cells secrete some proteins in 
a constitutive fashion. Some cell-types are known to 
exhibit an additional, triggered form of secretion [7]. 
Proteins destined for this regulated secretory pathway 
are sorted from constitutively secreted proteins in the 
TGN where they are packaged into special organelles, 
referred to as regulated secretory granules, that subse- 
quently undergo a process of maturation [8]. The ma- 
ture secretory granules are stored in the cytoplasm and 
do not release their content unless a specific signal in- 
duces their fusion with the plasma-membrane [9]. We 
chose the neuroendocrine c ll-line PC12 to localize 
rabl lp, as both the constitutive and the regulated secre- 
tory pathway have been well described for this cell-line 
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[1]. Using an approach based on immunoisolation f
well-characterized sulfate-labeled markers [10], we were 
able to show that rabllp is associated with both the 
constitutive and the regulated secretory pathway in 
PC12 cells. 
2. MATERIALS AND METHODS 
2.1. Preparation of antisera gainst rabllp 
The polyclonal antibody 121 was raised against recombinant 
rabl lp expressed in E. coli BL21(DE3) using the pET8c expression 
system [11]. Expression and purification of the rab-protein was essen- 
tially as previously described inLombardi et al. [12] and the purity was 
monitored by SDS-PAGE. 
2.2. Preparation of an ajfinity-purified and an immunodepleted antise- 
rum .fraction 
In order to generate an affinity-purified antibody and a fraction of 
the antiserum that was depleted of rabl -specific antibodies, 2 ml of 
the antiserum 121 were incubated for 2 h at 4°C with 2 ml of an affinity 
resin (MS2-polymerase-rabl l-fusion-protein coupled to a CNBr-acti- 
vated Sepharose-4B column) as previously described [13]. The flow- 
through of this column was collected and the specific antibodies were 
eluted from the column as previously described [13]. After reequilibra- 
tion of the column, the flow-through was passed a second time over 
the column. The relative antibody-concentration of the collected flow 
through of this second passage, referred to below as 'flow through' 
(FT) was analyzed by measurement of the OD at 280 nm and by 
immunofluorescence on fixed cells. As expected, only a minor fraction 
of the antibody bound to the affinity-purification column. 
2.3. Immunoprecipitation of i vitro translated protein 
In vitro translated protein was prepared essentially as previously 
described [14]. For immunoprecipitation under native conditions 10 
/11 of the antiserum was incubated for 30 min at room temperature with 
20 ¢tl of 10% w/v Protein A-Sepharose (Pharmacia) equilibrated in 
IP-buffer (10raM Tris pH 7.3, 150 mM NaCI, 1 mM EDTA). The 
unbound serum was removed, the beads were washed three times with 
IP-buffer and incubated for 1 h at room temperature with the in vitro 
translation reaction in a final volume of 150ktl. The beads were washed 
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twice with IP-buffer supplemented to final concentration f 1% Triton 
X-100 and twice with 10 mM HEPES, before resuspension i SDS 
sample buffer. The antibody-Protein A-Sepharose coupling for im- 
munoprecipitations under denaturing conditions was carried out in 
buffer A (0.2% v/v Triton X-100, 10 mM Tris pH 7.5, 150 mM NaCI, 
2 mM EDTA). After several washes in buffer A the beads were resus- 
pended in buffer B (20 ¢tl 2% Triton X-100, 0.4% SDS, 50 mM Tris 
pH 7.5, 150 mM NaCI, 2 mM EDTA). In vitro translation reactions 
were denatured in 4% SDS and then brought o the same conditions 
as buffer B. The denatured proteins were incubated for 2 h at room 
temperature with the antibody-bead complex. The beads were washed 
twice in buffer A, once in 10 mM Tris pH 7.5 and the precipitated 
proteins were lysed in SDS sample buffer, analyzed by SDS-PAGE 
and fluorography. 
2.4. Cell culture 
PC12 cells (clone 251, [15], originally obtained from Dr. H. Thoe- 
nen, Martinsried, Munich) were grown i  DMEM supplemented with 
10% horse serum and 5% fetal calf serum (growth medium) as previ- 
ously described [1]. 
2.5. [35S]sulfate labelling of PC12 cells 
PC12 cells were pulse labeled and pulse labeled and chased (as 
indicated in the figure legends) with [35S]sulfate exactly as described 
in Tooze et al, 1990 [1]. 
2.6. EXPRE35S35S labeling of PC12 cells 
PC12 cells were incubated for 30 min at 37°C in methionine-cyste- 
ine-free medium (DMEM lacking methionine and cysteine plus 1% 
dialyzed horse serum and 0,5% dialyzed fetal calf serum) in order to 
deplete ndogenous methionine and cysteine. Cells were then either 
pulsed with EXPRE35S3SS (L-[35S]methionine and L-[35S]cysteine; spec. 
activity: 1140 Ci/mmol. Amersham) or pulsed and then chased with 
growth medium supplemented with 1% of the level of normal methion- 
ine and cysteine as described in the figure legends. To chase the label 
and in long-term (16 h) labeling incubations, the typically 1 to 2 mCi 
of EXPRE35S35S label was used per 15 cm dish. 
2.7. Subcellular fractionation of PC12 cells 
CSV and ISG were separated from the TGN by velocity and equi- 
librium sucrose gradient centrifugation aspreviously described [1,10]. 
Fractions 2~, or 5-7 of the velocity gradient, containing the bulk of 
CSV and ISG, or MSG respectively were subjected to equilibrium 
sucrose gradient centrifugation. The fractions from the velocity and 
the equilibrium gradient were analysed by SDS-PAGE and fluorogra- 
phy. For some experiments a total membrane fraction was prepared 
from a PNS as follows: 1.0 ml of a PNS was loaded on top of a 0.3 
M Sucrose-cushion (0.4 ml) and centrifuged for 30 min at 45,000 rpm 
in a TLS 5,55 rotor in a TL 100-ultracentrifuge (Beckmann). The 
supernatant was removed and the pellet was taken up either in homog- 
enization buffer, immunoisolation buffer, IEF sample buffer o SDS- 
sample buffer. For the determination of relative protein concentra- 
tions, a fixed volume of each fraction, derived from metabolically 
labeled cells, was applied to a Whatman 3MM 2.5 cm filter, precipi- 
tated with 10% TCA for 10 min at 4°C, washed with 5% TCA at 95°C 
for 5 rain and rinsed for 5 min at 4°C with ethanol/ether (1:1). TCA- 
precipitated counts were analysed by scintillation counting (Wal- 
lacl410 Liquid Scintillation Counter, Pharmacia) 
2.8. Immunoblotting 
For Western blot analysis, proteins were separated either by 12.5% 
SDS-PAGE or by high resolution 2D gel electrophoresis and subse- 
quently transferred onto nitrocellulose filters. Filters were blocked for 
16h at 4°C with PBS/5% milk powder, 0.2% Tween 20. Incubations 
with primary antibody were for 2 h at room temperature in PBS/5% 
milk, 0.2% Tween 20. After extensive washing with the same buffer, 
membranes were incubated with 0.138 pCi/ml ~25I-labeled Protein A 
(spec. activity: 8.91 ~tCi/pg; DuPont) in PBS/5% milk, 0.2% Tween 20 
for 1 h at room temperature, washed s veral times with PBS/0.2% 
Tween 20, dried and exposed at -80°C. Subsequently immunoblots 
were quantitated by analysis with a PhosphorImager and the 
ImageQuant Softwarepacket (Molecular Dynamics). 
2.9. lmmunoisolation 
Staphylococcus aureus cells (Staph A) were formalin-fixed and heat- 
inactivated by Kessler's procedure [16]. The thawed cells were equili- 
brated at a concentration f 10% (w/v) in immunoisolation buffer (IB, 
50 mM Tris, pH 7.5; 150 mM NaC1 and 2 mM MgC12) supplemented 
with 0.5% BSA (lyophilized, fatty acid-free BSA, Sigma) by three 
washing steps (cycles of resuspension and centrifugation for 20 s at 
10,000 rpm approx. (8800xg) in an Eppendorf centrifuge). The follow- 
ing incubations and washing steps were all carried out at 4°C on a 
rotating wheel. With the exception of the samples prepared for elec- 
tron microscopy, 200 ,ul washed Staph A was incubated prior to 
antibody coupling for 2h with 200 ,ul of a cold PNS, prepared from 
a 15 cm dish of 80% confluent cells. The 'precoated' Staph A was 
incubated for 16 h with 20pl of antiserum 121 or with the immunode- 
pleted antiserum ('flow through'). Excess antibody was removed by 
three washing steps with IB/0.5% BSA and the Staph A-antibody 
complex was incubated for 2 h with 200 pl of a labeled PNS, obtained 
from a 15 cm dish of 80% confluent cells. For the immunoisolation 
from subcellular f actions, the volume of the input was normalized to 
the amount of antigen quantitated by immunoblotting of the respec- 
tive fractions. All immunoisolation experiments were carried out in 
excess of antibody-Staph A complex. Unbound material was removed 
by two washing steps with IB/BSA followed by two washes with IB. 
The pellet was resuspended in IEF sample buffer or SDS sample buffer 
for biochemical nalysis. When indicated, heat stable fractions were 
obtained by boiling samples for 5 min at 950C and pelleting the 
denatured protein for 5 min at 13.000 rpm in an Eppendorf centrifuge. 
2.10. Electron microscopy 
For analysis by electron microscopy, the Staph A pellet with the 
bound immunoisolated material was fixed for 30 min with 0.5% glu- 
taraldehyde. The pellet was gently washed with 0.1 M cacodylate 
buffer and processed for electron microscopy as previously described 
[17]. Ultrathin sections were cut and the ratio of dense core granules 
per Staph A was determined by counting at random 15 fields contain- 
ing a total of 180-200 profiles of Staph A particles. 
2.11. Two-dimensional (2D) gel electrophoresis, transfer to nitrocellu- 
lose blots and [o~-~2P]GTP overlay 
A combination of isoelectric focusing (IEF) and SDS-PAGE was 
used to resolve proteins in two dimensions essentially as described 
previously [18]. [~-32p]GTP overlays were performed as described re- 
cently [19,20]. [c~-32P] GTP binding was visualized by autoradiography 
(12~4 h, -80°C) using Kodak X-OMAT film with an intensifying 
screen. 
3. RESULTS 
3.1. Characterization o f  the antibody 121 
In  o rder  to invest igate  the loca l i za t ion  o f  the smal l  
GTPase  rab l  p ,  we ra ised ant ibod ies  aga ins t  the full  
l ength  recombinant  rab l  1 prote in  expressed  in bacter ia l  
cells. The  specif icity o f  the ant i serum 121 was ana lysed  
by  immunoprec ip i ta t ion  under  nat ive  and  denatur ing  
cond i t ions  w i th  in v i t ro  t rans la ted ,  [35S]methionine la- 
be led rab l lp .  To test  for  cross react iv i ty  w i th  o ther  
pro te ins  o f  the  rab- fami ly ,  we used in v i t ro  t rans la ted ,  
35 [ S ]meth ion ine- labe led  rab5p as a cont ro l .  Fig. 1 shows 
that  the ant i serum 121 specif ical ly recogn izes  rab l lp  
under  both  nat ive  and  denatur ing  cond i t ions  but  does  
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Fig. 1. Immunoprecipitation of in vitro translated rabllp. In vitro 
transcribed rabl 1- or rab5-mRNA was translated in reticulocyte ly- 
sate in the presence of [35S]methionine. Antiserum 121 was coupled to 
protein A-Sepharose and incubated either (a) under denaturing condi- 
tions (in the presence of SDS), or (b) under native conditions with 
untreated in vitro translation reactions (lanes 1 and 3, rabl lp; lanes 
2 and 4, rab5p). The immunoprecipitated proteins were resuspended 
in SDS sample buffer and analysed by 12.5% SDS-PAGE followed by 
fluorography. I, starting material; 121, immunoprecipitated fraction. 
not immunoprecipitate rab5p. From these data it can be 
concluded that the antiserum raised against rabl lp does 
not recognize the regions that are highly conserved 
within the rab-family. Furthermore this antibody recog- 
nizes only one spot on a blot of a two-dimensionally 
resolved immunoisolated fraction that was enriched for 
several GTP-binding proteins (see below and Fig. 5c 
and d). 
3.2. Biochemical localization of rabllp on PC12 cells in 
TGN and post TGN vesicles 
Intracellular labelling obtained by indirect im- 
munofluorescence as well as immunogold labelling on 
cryosections of different cell types suggested that at least 
part of the endogenous rabl lp-pool might be associated 
with vesicular structures in the area of the trans-Golgi 
network (TGN) as well as in the cell periphery (data not 
shown). However, due to the low level of labeling on 
cryosections, we were not able to draw solid conclusions 
from our morphological data. Therefore we decided to 
use a biochemical approach in order to examine the 
localization of rabl lp.  Previously it has been shown 
that rabl lp is highly expressed in secretory tissues [6]. 
We chose the well-studied secretory cell line PC12 (a rat 
cell line derived from a pheochromocytoma) to analyze 
the distribution of rabl lp. A system based on this cell 
line has been described that allows the separation and 
resolution of at least two different ypes of secretory 
vesicles from each other and from their donor compart- 
ment, the TGN [1]. Briefly, following a velocity centrif- 
ugation of a post-nuclear supernatant (PNS) over a 
linear sucrose gradient, TGN-derived membranes sedi- 
ment as a peak in the denser part of the gradient, 
whereas post-TGN vesicles migrate towards the top. By 
immunoblotting with antisera 121, rabl lp was found in 
both the fractions containing TGN-derived membranes 
(Fig. 2; fractions 9, 10 and 11) and the fractions contain- 
ing post-TGN vesicles (Fig. 2; fractions 2 and 3). This 
result did not merely reflect the protein distribution 
over the gradient, as for each fraction an equal amount 
of TCA-precipitable proteins was separated by SDS- 
PAGE and quantitatively analysed. 
3.3. Immunoisolation of rabllp-positive membranes 
from PC12 cells 
To further characterize the vesicles with which 
rabl lp is associated, we decided to make use of a system 
that is based on sulfation of proteins, a post-transla- 
tional modification occurring in the trans-Golgi net- 
work [10]. In PC12 cells, two of the three major sulfated 
proteins, Secretogranin I and II have been shown to be 
sorted efficiently into secretory granules, whereas a 
third sulfated protein, a heparansulfate proteoglycan, is 
constitutively secreted [1]. Using pulse-chase xperi- 
ments of [35S]sulfate-labeled PC12 cells, markers of the 
constitutive and the regulated secretory pathway can 
therefore be followed upon exit from the TGN. After 
velocity centrifugation (described above) a second cen- 
trifugation step allows the separation of constitutive 
secretory vesicles from immature secretory granules. A 
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Fig. 2. Distribution of rabl lp on a gradient separating TGN-derived 
vesicles from the TGN. PC12 cells were metabolically abeled for 16 
h with [3SS]methionine. A PNS was prepared from these cells and 
subjected to velocity sucrose centrifugation. Fractions 2-13 were 
TCA-precipitated and an equal number of TCA-precipitable counts 
was subjected to 12.5% SDS-PAGE. Proteins were transferred onto 
nitrocellulose filters and blotted with affinity-purified antibody 121. 
Bound antibodies were detected with ~25I-labeled protein A and subse- 
quently visualized by autoradiography (a). Quantitation was done by 
analysis with a PhosphorImager and the ImageQuant Software packet 
(b). An arrow indicates the position of rabl p. 
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Fig. 3. Immunoisolation f membrane vesicles from sulfate-labeled PC12 cells. PC12 cells were labeled with [35Slsulfate either by (a) a 5 min pulse, 
(b,c) a 5 rain pulse followed by a 15 min chase, or (d) 6 h labeling followed by 18 h of chase to label proteins at different stages of the exocytic 
pathway (TGN, trans-Golgi network; CSV, constitutive secretory vesicles; ISG, immature secretory granules; MSG, mature secretory granules). 
The PNS from each of the three conditions was subjected to velocity sucrose gradient centrifugation. Fractions 9 and 10 containing the peak of 
the labeling in condition (a) were kept on ice and used later for immunoisolation (TGN). Fractions containing the peak of the labeled proteins 
of conditions (b,c) and (d) were collected into two separate pools (fractions 24  and fractions 5-7 respectively) and submitted to equilibrium sucrose 
gradient centrifugation for further separation. Fractions from the equilibrium gradient of condition (b/c) containing either (b) the bulk of the hsPG, 
the constitutive marker (fractions 5and 6), or (c) the regulated secretory proteins, SgI and SglI (fractions 8and 9) were pooled and used as starting 
material for two immunoisolations (CSV, ISG). Fractions from the bottom of equilibrium gradient (d) containing long-term labeled secretogranins 
SgI and SglI (fractions 11 and 12) were used for immunoisolation f MSG. For each immunoisolation a  equal volume of starting material was 
incubated with precoated Staph A-antibody 121 complex (3), or incubated with precoated Staph A alone (2) or kept on ice and acetone-precipitated 
(1). lmmunoisolated material was analysed in parallel with the starting material by 7.5% SDS-PAGE and subsequent fluorography. Brackets 
indicate the heparansulfate proteoglycan (hsPG). Filled arrowheads indicate secretogranin II (SglI), whereas empty arrowheads indicate the position 
of secretogranin I (SgI). 
long term incubation with [35S]sulfate followed by an 
extended chase period (18 h) restricts the labeling to 
mature secretory granules that can be separated from 
tess dense vesicles (including constitutive secretory vesi- 
cles and immature secretory granules) by the same cen- 
trifugation steps. Starting from four different pools of 
gradient fractions, containing either the TGN (as identi- 
fied by a 5-min sulfate pulse), constitutive secretory 
vesicles and immature secretory granules both labeled 
by a 5 rain sulfate pulse followed by a 15 rain chase or 
mature secretory granules (labeled by a 6 h sulfate- 
labeling followed by 18 h chase), we asked whether the 
antibody 121 could specifically immunoisolate any of 
these labeled compartments. Surprisingly, we were able 
to immunoisolate all four compartments with high effi- 
ciency (Fig. 3a-d). The specificity of this result was 
shown by several criteria. First, Staph A alone without 
coupled antiserum did not reveal any significant ability 
to bind labeled vesicles (Fig. 3, lane 2). Second, a similar 
immunoisolation experiment s arting from a membrane 
fraction prepared from a PNS of metabolically pulse- 
labeled or pulse-labeled and chased cells showed that 
rabl lp is not associated with the early secretory path- 
way (Fig. 4); secretogranin I and II labeled by a 5 min- 
ute [35S]methionine pulse (which should identify the pro- 
teins while they are still present in the endoplasmic retic- 
ulum) could not be efficiently immunoisolated (lanes 1 
and 3) whereas after 20 min of chase the same proteins 
appeared to be isolated with high efficiency in a later 
stage of the secretory pathway (lanes 2 and 4). The 
apparent shift in molecular weight of SgI confirmed that 
the marker proteins had indeed reached a late Golgi or 
post-Golgi compartment [21]. Finally, a fraction of the 
antiserum that had been previously depleted by affinity 
absorption of rabllp-specific antibodies (the flow 
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Fig. 4. Immunoisolation of membrane vesicles from metabolically- 
labeled PC12 cells. PC12 cells were either pulse-labeled for 5 rain with 
[35S]methionine (lanes 1,3,5,7) or pulse-labeled (5 rain) and chased for 
20 rain (lanes 2,4,6,8). A total membrane fraction was prepared from 
the PNS obtained from each of the conditions and equal parts were 
either incubated with precoated Staph A that was coupled with anti 
rabl lp antiserum (121), with a fraction of the antiserum that was 
depleted of specific antibodies (FT, flow through), with an antiserum 
raised against secretogranin II (SgII), a luminal antigen, or simply left 
on ice (I, input). A heat-stable fraction was obtained of the immuno- 
isolated material and the input-fraction and analyzed by 7.5% SDS- 
PAGE followed by fluorography. The heat stable proteins ecreto- 
granin I and II are indicated with an empty (SgI) and a filled (SgII) 
arrowhead. The asterisk marks the higher molecular weight form of 
SgI characteristic of the trans-Golgi form as opposed to the rough ER 
form (filled arrowhead) 
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Fig. 5.2D gel analysis of the immunoisolation by [3ZP]GTP overlay (a and b) and [12sI]Protein A-immunoblot (cand d). (a) and (b): A PNS was 
prepared from PC12 cells and a total membrane fraction wasobtained. Equal parts of the membrane fraction were incubated with precoated Staph 
A coupled with antiserum 121 and lysed in IEF sample buffer. Immunoisolated material (b) was solubilised in IEF sample buffer and analysed 
in parallel with the starting material (a) by 2D gel analysis followed by [32p]GTP overlay and subsequent autoradiography. (c) and (d). PC12 cells 
were labeled for 16 h with [35S]methionine and a membrane fraction from a PNS was prepared. An aliquot of the membrane fraction was incubated 
with precoated Staph A coupled with antiserum 121whereas another part was lysed in IEF sample buffer. Bound material was solubilised in 
IEF-buffer and an equal amount of TCA-precipitable counts of both the membrane fraction (c) and the immunoisolated fraction (d) were analysed 
by 2D gel analysis. Separated proteins were transferred to nitrocellulose filters and immunoblotted with affinity-purified antiserum 121. Bound 
antibodies were detected by[~25I]Protein A and quantitation (see bar-diagram) was done with a PhosphorImager. Large arrows indicate the position 
of rabl lp; small arrows indicate the rab5p-isoforms; large arrowheads indicate rab3p and small arrowheads indicate rab6p. The asterisk marks 
a ubiquitous unidentified GTP-binding protein. 
through from the affinity column), only displayed a low 
level of  background signal (Fig. 4, lanes 5 and 6). Fur-  
thermore, the observed signal could not  be accounted 
for by non specific binding after lysis of  the compart -  
ments, as an immunoiso lat ion with an ant ibody raised 
against secretogranin I I  (a luminal antigen) gave a very 
low signal (Fig. 4, lanes 7 and 8). Therefore we conclude 
that rab l lp  is indeed associated with the TGN and 
TGN-der ived  vesicles compris ing both constitutive se- 
cretory vesicles as well as immature and mature secre- 
tory granules. 
3.4. Two-dimensional gel analysis of immunoisolated 
membrane fractions 
Analysis of  the immunoiso lated fraction by [32p]GTP 
overlay of  two-dimensional  gels showed a simplified 
pattern compared to the membrane fraction used as 
starting mater ia l  (Fig. 5b and a). In part icular,  the sig- 
nal of  the rab5p- isoforms [19], that have previously 
been localized to the early endocytic pathway [22], were 
dramat ical ly  decreased in the immunoisolate.  In con- 
trast a few GTP-b ind ing proteins appeared to be en- 
r iched in the immunoiso lated fraction. One of  these 
proteins might correspond to rab6p which has been 
localized previously to the TGN [23,24] and to a post- 
Golgi  vesicle [25]. Interestingly the signal corresponding 
to rab3p [19] was decreased after the immunoisolat ion.  
The detection o f rab l  lp  in [32p]GTP-overlays of 2D gels 
proved problemat ic  as overexpression studies showed 
that rab l  lp  is poor ly  resolved from a yet unidentified, 
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Fig. 6. Electron microscopic analysis of the immunoisolated fraction. Antirabl 1 antiserum adsorbed to Staph A was incubated with a total 
membrane fraction from PC12 cells as d scribed insection 2. The Staph A with associated immunoisolated material was then washed, fixed, and 
processed for electron microscopy. The material associated with the Staph A particles (s) comprises uncoated electron lucent vesicles(arrows) and 
vesicles with an electron dense content (arrowheads). T  latter have the characteristic morphology of secretory granules as shown at higher 
magnification in the inset. Bars, 200 nm. 
prominent spot (*), that is found in every membrane 
fraction [19]. Therefore we investigated the enrichment 
of rabl lp in the immunoisolate by immunoblotting. A 
PNS was obtained from metabolically labeled PC12 
cells and the membrane fraction prepared from this 
PNS was used as a starting material in an immunoisola- 
tion experiment. We then compared equal amounts of 
TCA-precipitable counts of the starting material and 
the immunoisolate by immunodetection  a Western 
blot from a 2D gel. Only one spot was revealed by the 
anti rabl lp antibody which, as indicated in previous 
experiments with overexpressed rab 11 p-protein (results 
not shown), lay in the same position as the prominent 
ubiquitous GTP-binding protein (spot (*)) (Fig. 5c and 
d). Quantitation of the immunoblots showed a 6.5-fold 
enrichment of rab 1 l p in the immunoisolate (Fig. 5, bar- 
chart), consistent with the conclusion that our data re- 
flect a specific interaction of the antiserum with rabl lp. 
The fact that only one spot is detected by the antibody 
in the immunoisolated fraction shows that the enrich- 
ment observed for other GTP-binding proteins in this 
fraction (Fig. 5b) is not due to a crossreactivity of the 
antiserum with these proteins and shows the specificity 
of the immunoisolation procedure. 
3.5. Electron microscopy of the immunoisolated mem- 
brane fraction 
To determine morphologically what type of struc- 
tures were specifically immunoisolated by the antisera 
121 we performed electron microscopy after immuno- 
iCsolation (Fig. 6). Apart from dense-core granules of 
mature appearance, some granules with an irregular 
shape typical for immature granules were also detected 
in the preparation. Structures reminiscent of condens- 
ing vacuoles were also observed (data not shown), in 
agreement with our biochemical finding of rabl lp on 
the TGN membranes. Furthermore other smaller vesic- 
ular profiles of translucent appearance were observed 
(Fig. 6) which might correspond to constitutive secre- 
tory vesicles or to tubular structures of the TGN. We 
quantitated the number of dense-cored secretory gran- 
ules per Staph A to evaluate the specificity of the immu- 
noisolation. Comparison of fractions immunoisolated 
using the complete antiserum or the antiserum depleted 
of rabl lp-specific antibodies howed a 7.4-fold higher 
density of dense-core granules per Staph A in the immu- 
noisolated fraction btained with complete antiserum. 
4. DISCUSSION 
The localization of proteins of the rab-family by con- 
ventional methods uch as indirect immunofluorescence 
and immunogold labeling has often proved to be 
problematic. Many antibodies raised against his class 
of proteins react poorly with the endogenous protein on 
cells processed for immunoelectron microscopy, so that 
the specific labeling is barely discernible. In our at- 
tempts to localize rab 1 lp, we therefore adopted an ap- 
proach based on immunoisolation of pulse-chase la- 
beled markers with a polyclonal antibody that specifi- 
cally recognized the native form of rabl lp .  To our 
knowledge this is the first time a member of the rab- 
family has been localized using this technique. We have 
excluded possible crossreactivity of the antibody with 
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other members of the rab-family by showing that this 
antibody only reacts with a single protein on a two- 
dimensionally resolved immunoisolated fraction al- 
though this fraction was enriched for several GTP-bind- 
ing proteins. Amongst these proteins, rab l lp  was 
shown to be enriched 6.5-fold. 
Using a combination of immunoisolation experi- 
ments and different metabolic labeling procedures of 
known secretory proteins in PCt2 cells, we were able to 
identify the subcellular distribution of rabl 1 p. Two se- 
cretory proteins, SgI and SgII, labeled by a short pulse 
of [35S]methionine at the site of protein synthesis could 
not be specifically detected (in significant amounts) in 
an immunoisolated fraction. However, if the labeled 
proteins were chased to a late secretory compartment 
(TGN and post-TGN), the signal detected in the specific 
immunoisotated fraction was significantly higher than 
in control samples. The same proteins labeled with 
[35S]sulfate were already detectable in the immunoiso- 
late at the earliest measurable time point of sulfate in- 
corporation, that is in the TGN. Furthermore, these 
labeled proteins could be immunoisolated after their 
exit from the TGN and appearance in secretory vesicles. 
Therefore, our data show that rabl lp is associated with 
both the TGN and TGN-derived vesicles. 
Both a constitutively secreted heparansulfate pro- 
teoglycan (hspG) and two granule specific proteins (SgI 
and SgII) can be efficiently labeled with [35S]sulfate in 
the TGN in PC12 cells. Using these proteins as markers, 
we were able to show that rabl lp is associated with 
both constitutive secretory vesicles and regulated secre- 
tory granules. It is unlikely that the rabl lp found on the 
secretory granules is a result of a missorting of rabl lp 
to the regulated secretory pathway as we find no other 
known TGN-localized rab-protein, such as rab8p, on 
regulated secretory g anules (data not shown). Further- 
more, the efficiency of the immunoisolation suggests 
that rabl lp is associated with a large proportion of the 
mature secretory granules. The presence of rabl lp on 
both constitutive and regulated secretory pathways and 
its tissue distribution make it unlikely that the function 
of rabl lp is involved in a process that is restricted to 
the regulated secretory pathway. Indeed, the existence 
of a highly homologous protein in yeast, ypt3 [5,26] 
suggests that this protein even plays a role in a lower 
eucaryote for which no regulated secretion has been 
described so far. Recently it has been postulated that 
both constitutive and regulated secretion are based on 
the same principles with the exception of an inhibitory 
factor, restricted to the regulated secretory pathway and 
neutralized only in response to an extracellular trigger 
[27]. Our results on the localization of a rab-protein to 
both constitutive secretory vesicles and regulated secre- 
tory granules strengthens the idea of a basic similarity 
between constitutive and regulated secretion. What 
might be the function of rabl lp? Members of the ypt! 
rab family have been postulated to be involved in the 
targeting of transport vesicles to different subcellular 
compartments [2,4,28]. In this context, we suggest a 
putative role for rabl lp in a specific recognition process 
at the plasma membrane, as a common destination for 
both the constitutive and the regulated secretory path- 
way. This raises the possibility that other organelles that 
are targeted to the plasma membrane might also utilize 
rabl lp. In this context it is interesting to note that a 
homologue of rab l lp ,  ora3 [29], (96.9% identity with 
rabl lp [5] over the sequence spanning region 1 to region 
4; Urb6 and Parton, in preparation), although ubiqui- 
tously expressed [29], is associated with cholinergic syn- 
aptic vesicles derived from the electric organ of the ma- 
rine ray [30]. Further work will be required to determine 
other possible locations of rabl lp and to ascertain its 
function. 
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